NEW YORK (GenomeWeb News) – Metabolon has raised $5.3 million from a Series C funding round, the firm said today.

The Research Triangle Park, NC-based metabolomics services company said that it anticipates raising a total of $11 million in the round. It closed the first $5.3 million last week, and it expects to receive the rest of the funding within the next 60 to 90 days.

Metabolon CEO John Ryals said that the funding will enable the firm to launch its diagnostics business with products for prostate cancer and insulin resistance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.